VU 0361737 is primarily used in research settings as a selective positive allosteric modulator of the M1 muscarinic acetylcholine receptor. It is employed to study the role of M1 receptors in the central nervous system, particularly in relation to cognitive functions such as learning and memory. This compound has shown potential in preclinical studies for improving cognitive deficits associated with neurological disorders like Alzheimer's disease. Additionally, it is utilized to explore therapeutic strategies for schizophrenia and other psychiatric conditions where M1 receptor modulation may offer benefits. Its application helps in understanding the underlying mechanisms of these disorders and in developing targeted treatments.